Lexicon Pharmaceuticals (LXRX) Preferred Shares (2024 - 2026)

Lexicon Pharmaceuticals (LXRX) posted quarterly Preferred Shares of $4000.0 for Q1 2026, down 82.61% quarter-over-quarter from $23000.0 in Q1 2024.

Lexicon Pharmaceuticals (LXRX) Preferred Shares (2024 - 2026) Analysis & Trends

Lexicon Pharmaceuticals (LXRX) has reported Preferred Shares for 2 consecutive years, with $4000.0 the latest figure, recorded in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Lexicon Pharmaceuticals 1.04 Bn 846.13 Mn 653,000.00 -

Historic Data

Download Data
DateValue
Mar 31, 2026 4,000.00
Mar 31, 2024 23,000.00